Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 1 of 1 for:    study of hydroxychloroquine in combination with FOLFOX plus bevacizumab to inhibit autophagy in colorectal cancer
Previous Study | Return to List | Next Study

FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01206530
First received: September 16, 2010
Last updated: April 4, 2017
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)